Taking steps to deliver telemedicine in today’s movement disorders practice

Telemedicine is feasible and cost-effective, with comparable health outcomes and high patient and physician satisfaction, said Professor Ali Shalash, of the Ain Shams University, Cairo, Egypt speaking at the 2019 MDS Congress. Telemedicine has several applications in Parkinson’s disease and other movement disorders, and with advancing technology will allow more individuals to connect directly to health care or indirectly to the expertise that they need.

Why telemedicine for movement disorders?

Telemedicine or “healing at a distance” involves the remote delivery of healthcare services using telecommunications technology, and its primary purpose is to increase access to care.1

The burden of Parkinson’s disease (PD) and other movement disorders will increase rapidly, with the number of people living with PD projected to rise to nearly 9 million in the world’s 10 most populous nations by 2030 (from 4 million in 2005).2 Yet, the available resources for neurological disorders within most countries remain insufficient,3 and the demand for in-home care is likely to grow along with new emerging home-based care models that include remote and self-monitoring and multidisciplinary care.4,5

The application of telemedicine in PD will allow for remote consultation, synchronous motor assessment of PD6 remote synchronous follow-up visits, i.e. assessment at home or in nursing homes,7 the integration of wearable sensors and at home devices (telemetry),8,9 telerehabilitation of specific symptoms, e.g. speech,10 dysphagia,11 gait,12 the follow up of advanced therapies of PD13, 14,  telepsychiatry,15 access to multidisciplinary care16 and increased service provision to improve outcomes.

The use of telemedicine in Parkinson’s disease has multiple applications and the potential to improve access to multidisciplinary care

Synchronous methods include teleconferencing and video conferencing to provide patient care or provider consultation and rely on a live audio-visual feed for the exchange of information. Asynchronous methods rely on store-and-forward technology – this includes email, transmission of still images or video recordings, smartphone assessments, or remote sensors –and are not reviewed in real time.17


Telemedicine in practice: a how to guide

As Chair of the Movement Disorders Society (MDS) Telemedicine Study Group, Dr Esther Cubo Delgado, Hospital University Burgos, Spain outlined 5 key steps involved in introducing telemedicine into movement disorders practice:18

  • Obtain equipment and video visit software
  • Ensure necessary licensure/registration
  • Determine financial support
  • Set up video exam rooms
  • Conduct the visit.

The implementation of a multidisciplinary approach will require: a central heath record (if the patients is seen by different health care professionals), multidisciplinary consultations to be performed in a single visit, and asynchronous telemedicine utilizing emails/phone calls/texts in underserved areas with limited technology access.19


Other opportunities

There are large inequalities across regions and different income levels, with extremely scanty neurological healthcare resources in lower income countries requiring a need for substantial increase in neurology services and training.3 Tele-education may provide a way to address such inequalities, an example of which has provided tele-education in PD to healthcare providers in Cameroon.20

Telemedicine may help to address inequalities in provision of neurological healthcare across regions and countries with different income levels


Critical challenges

Critical challenges to address for the wider adoption of telemedicine in neurological disorders include the integration of systems for data monitoring with an easy-to-use, secure, and cost-effective platform that can be adopted by patients and healthcare systems. In future, integrated efforts from multiple stakeholders will be needed to develop an interoperable software platform capable of providing a holistic approach to care and reducing disparities in access to care.21

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.


1. Strehle EM and Shabde N. One hundred years of telemedicine: does this new technology have a place in paediatrics? Arch Dis Child. 2006;91(12):956-9.

2. Achey M et al. The past, present, and future of telemedicine for Parkinson's disease. Mov Disord. 2014;29(7):871-83.

3. WHO. Atlas Country Resources for Neurological Disorders. Second Edition 2017. ISBN: 978-92-4-156550-9

4. Radder DLM et al. Multidisciplinary care for people with Parkinson’s disease: the new kids on the block! Expert Rev Neurother. 2019;19(2):145-57.

5. Ben-Pazi H et al. The promise of telemedicine for movement disorders: An interdisciplinary approach. Curr Neurol Neurosci Rep. 2018;18(5):26.

6. Sekimoto S et al. A randomized crossover pilot study of telemedicine delivered via ipads in Parkinson’s disease. Parkinson’s Disease. 2019;Article #9403295.

7. Dorsey ER et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010;25(11):1652-9.

8. Silva de Lima AL et al. Home‐based monitoring of falls using wearable sensors in Parkinson's disease. Mov Disord. 2019;26 Aug Epub: https://doi.org/10.1002/mds.27830

9. Delprato U et al. PARKSERVICE: Home support and walking aid for people with Parkinson's disease. Stud Health Technol Inform. 2006;121:1-6.

10. Dias AE et al. Voice telerehabilitation in Parkinson's disease. Codas. 2016;28(2):176-81.

11. Ward EC et al. Validity of conducting clinical dysphagia assessments for patients with normal to mild cognitive impairment via telerehabilitation. Dysphagia. 2012;27(4):460-72.

12. Gandolfi M et al. Virtual reality telerehabilitation for postural instability in Parkinson's disease: A multicenter, single-blind, randomized, controlled trial. Biomed Res Int. 2017:7962826.

13. Li D et al. Remotely programmed deep brain stimulation of the bilateral subthalamic nucleus for the treatment of primary Parkinson disease: a randomized controlled trial investigating the safety and efficacy of a novel deep brain stimulation system. Stereotact Funct Neurosurg. 2017;95(3):174-82.

14. Willows T et al. Initiation of levodopa-carbidopa intestinal gel infusion using telemedicine (video communication system) facilitates efficient and well-accepted home titration in patients with advanced Parkinson's disease. J Parkinsons Dis. 2017;7(4):719-28.

15. Butterfield LC et al. The Parkinson's Active Living (PAL) Program. J Geriatr Psychiatry Neurol. 2017;30(1):11-25.

16. Pretzer-Aboff I and Prettyman A. Implementation of an integrative holistic healthcare model for people living with Parkinson's disease. Gerontologist. 2015;55(Suppl 1):S146-53.

17. Schneider RB and Biglan KM. The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease. Lancet Neurol. 2017;16(7):541-51.

18. Spindler M and Martin J. Telemedicine in your movement disorders practice: A step-by-step guide. December 2018. https://www.movementdisorders.org/MDS/About/Committees--Other-Groups/Tel... (Accessed 24 September 2019).

19. Patel UK et al. Multidisciplinary approach and outcomes of tele-neurology: A review. Cureus. 2019;11(4):e4410.

20. Cubo E et al. A Parkinson's disease tele-education program for health care providers in Cameroon. J Neurol Sci. 2015;357(1-2):285-7.

21. Chirra M et al. Telemedicine in neurological disorders: Opportunities and challenges. Telemedicine and e-Health 2019;25(7): 11 July Epub: https://doi.org/10.1089/tmj.2018.0101.

You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country